ES2193185T3 - Formulacion farmaceutica para la prevencion o tratamiento previo de una intoxicacion con inhibidores de la colinesterasa organofosforados. - Google Patents

Formulacion farmaceutica para la prevencion o tratamiento previo de una intoxicacion con inhibidores de la colinesterasa organofosforados.

Info

Publication number
ES2193185T3
ES2193185T3 ES95903322T ES95903322T ES2193185T3 ES 2193185 T3 ES2193185 T3 ES 2193185T3 ES 95903322 T ES95903322 T ES 95903322T ES 95903322 T ES95903322 T ES 95903322T ES 2193185 T3 ES2193185 T3 ES 2193185T3
Authority
ES
Spain
Prior art keywords
cholinesterase
inhibitors
prevention
pharmaceutical formulation
organophosphorated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95903322T
Other languages
English (en)
Inventor
Thomas Hille
Walter Muller
Bodo Asmussen
Aharon Levy
Yacov Meshulam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Israel Institute for Biological Research
Original Assignee
LTS Lohmann Therapie Systeme AG
Israel Institute for Biological Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6504683&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2193185(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LTS Lohmann Therapie Systeme AG, Israel Institute for Biological Research filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2193185T3 publication Critical patent/ES2193185T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

UNA FORMULACION FARMACEUTICA PARA LA PREVENCION O PRETRATAMIENTO DE UN ENVENENAMIENTO POR INHIBIDORES ORGANOFOSFORADOS DE LA COLINESTERASA, CARACTERIZADO PORQUE CONSISTE EN UNA COMBINACION DE PRINCIPIOS ACTIVOS DE AL MENOS UN AGENTE MIMETICO Y OTRO LITICO DEL PARASIMPATICO.
ES95903322T 1993-12-10 1994-12-06 Formulacion farmaceutica para la prevencion o tratamiento previo de una intoxicacion con inhibidores de la colinesterasa organofosforados. Expired - Lifetime ES2193185T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4342173A DE4342173A1 (de) 1993-12-10 1993-12-10 Pharmazeutische Formulierung zur Prophylaxe bzw. Vorbehandlung einer Vergiftung durch phosphororganische Cholinesterasehemmer

Publications (1)

Publication Number Publication Date
ES2193185T3 true ES2193185T3 (es) 2003-11-01

Family

ID=6504683

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95903322T Expired - Lifetime ES2193185T3 (es) 1993-12-10 1994-12-06 Formulacion farmaceutica para la prevencion o tratamiento previo de una intoxicacion con inhibidores de la colinesterasa organofosforados.

Country Status (22)

Country Link
US (1) US6114347A (es)
EP (1) EP0732926B1 (es)
JP (1) JP3709204B2 (es)
KR (1) KR100374086B1 (es)
AT (1) ATE232726T1 (es)
AU (1) AU704020B2 (es)
CA (1) CA2178605C (es)
CZ (1) CZ291870B6 (es)
DE (2) DE4342173A1 (es)
DK (1) DK0732926T3 (es)
ES (1) ES2193185T3 (es)
FI (1) FI962369L (es)
HU (1) HUT74427A (es)
IL (1) IL111917A (es)
MY (1) MY116828A (es)
NO (1) NO962406L (es)
NZ (1) NZ277258A (es)
PL (1) PL314915A1 (es)
PT (1) PT732926E (es)
SK (1) SK282536B6 (es)
WO (1) WO1995015756A1 (es)
ZA (1) ZA949843B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2170649B1 (es) * 2000-03-29 2003-06-16 Ferrer Int Uso de la cdp-colina en el tratamiento de la abstinencia alcoholica.
EP1390032A4 (en) * 2001-05-11 2004-12-29 Marvin B Bacaner NOVEL QUATERNARY AMMONIUM COMPOSITIONS COUPLED WITH AUXILIARY ANIONS, USES THEREOF IN KITS AND THE USE THEREOF FOR PREVENTING AND TREATING CERTAIN CONDITIONS
GB2405336A (en) * 2002-05-01 2005-03-02 Eisai Co Ltd Cholinesterase inhibitors to prevent injuries caused by chemicals
DE10301851A1 (de) * 2003-01-17 2004-07-29 Lts Lohmann Therapie-Systeme Ag Verfahren zur medikamentösen Prophylaxe gegen Vergiftungen durch Cholinesterase-Hemmer, sowie hierfür geeignete Wirkstoffe und Arzneimittel
US20050013869A1 (en) * 2003-07-18 2005-01-20 Chaw Cheng Shu Sustained release formulation for carbamates and a method therefor
US20070093518A1 (en) * 2003-09-19 2007-04-26 Wetherell Janet R Pharmaceutical compositions for the treatment of organophosphate poisoning
US9308164B2 (en) * 2004-06-30 2016-04-12 Sovereign Pharmaceuticals, Llc Hyoscyamine dosage form
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
ES2519690T3 (es) * 2004-09-24 2014-11-07 University Of Maryland, Baltimore Método de tratamiento de envenenamiento por organosfósforo
CN111773389A (zh) * 2020-06-02 2020-10-16 杨卫国 一种治疗牛中毒的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3760806A (en) * 1971-01-13 1973-09-25 Alza Corp Helical osmotic dispenser with non-planar membrane
US3760805A (en) * 1971-01-13 1973-09-25 Alza Corp Osmotic dispenser with collapsible supply container
US3764984A (en) * 1972-01-28 1973-10-09 Benz G Information coding system
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3987790A (en) * 1975-10-01 1976-10-26 Alza Corporation Osmotically driven fluid dispenser
US4137300A (en) * 1976-08-20 1979-01-30 Ciba-Geigy Corporation Sustained action dosage forms
JPS5935920B2 (ja) * 1978-12-01 1984-08-31 フアイザ−・インコ−ポレ−テツド ２−ケトグロネ−トの製造方法
JPS60189744A (ja) * 1984-03-09 1985-09-27 Tokyo Color:Kk カラ−写真現像液の再生方法
JPS62133457A (ja) * 1985-12-04 1987-06-16 Konishiroku Photo Ind Co Ltd ハロゲン化銀カラ−写真感光材料の処理方法及び現像液処理装置
JPH03194552A (ja) * 1989-12-22 1991-08-26 Fuji Photo Film Co Ltd ハロゲン化銀カラー写真感光材料の処理方法
US5098819A (en) * 1990-01-31 1992-03-24 Knapp Audenried W Non-toxic photographic developer composition
US5278035A (en) * 1990-01-31 1994-01-11 Knapp Audenried W Non-toxic photographic developer composition for processing x-ray films in automatic film processors
DE4115558A1 (de) * 1991-05-13 1992-11-19 Dresden Arzneimittel Prophylaktisches antidot gegen phosphororganische gifte

Also Published As

Publication number Publication date
PT732926E (pt) 2003-06-30
CZ291870B6 (cs) 2003-06-18
IL111917A (en) 1998-08-16
NZ277258A (en) 1999-09-29
ZA949843B (en) 1995-09-01
FI962369A7 (fi) 1996-08-02
NO962406D0 (no) 1996-06-07
CA2178605C (en) 2006-02-14
FI962369A0 (fi) 1996-06-07
KR100374086B1 (ko) 2003-07-23
JPH09506361A (ja) 1997-06-24
MY116828A (en) 2004-04-30
AU704020B2 (en) 1999-04-15
PL314915A1 (en) 1996-09-30
HUT74427A (en) 1996-12-30
CA2178605A1 (en) 1995-06-15
DE4342173A1 (de) 1995-06-14
IL111917A0 (en) 1995-03-15
AU1242495A (en) 1995-06-27
US6114347A (en) 2000-09-05
KR960706341A (ko) 1996-12-09
FI962369L (fi) 1996-08-02
ATE232726T1 (de) 2003-03-15
DK0732926T3 (da) 2003-06-10
SK73896A3 (en) 1996-12-04
EP0732926B1 (de) 2003-02-19
JP3709204B2 (ja) 2005-10-26
DE59410246C5 (de) 2008-09-25
HU9601599D0 (en) 1996-08-28
CZ168396A3 (en) 1996-10-16
NO962406L (no) 1996-06-07
SK282536B6 (sk) 2002-10-08
DE59410246D1 (de) 2003-03-27
WO1995015756A1 (de) 1995-06-15
EP0732926A1 (de) 1996-09-25

Similar Documents

Publication Publication Date Title
ES2137372T3 (es) Solucion antifungica para las uñas.
ES2153836T3 (es) Composicion enmascaradora del sabor de agentes farmaceuticos amargos.
ATE234092T1 (de) 2-alkylpyrrolidine
BR9916518A (pt) Método para tratar ou prevenir um distúrbio de neoplasia em um mamìfero em necessidade de tal tratamento ou prevenção, e, combinação compreendendo um inibidor de ciclooxigenase-2 e um ou mais agentes anti-neoplásticos
GT199800126A (es) Terapia de combinacion.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
BR9911724A (pt) Ciclosporina que tem um perfil de atividade melhorado
ES2159591T3 (es) Composicion de liberacion controlada.
ES2044840T3 (es) Composiciones estabilizadas del activador del plasminogeno de tejido humano.
ES2193185T3 (es) Formulacion farmaceutica para la prevencion o tratamiento previo de una intoxicacion con inhibidores de la colinesterasa organofosforados.
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
SE9604348D0 (sv) Användning av hydroxyguanidiner
ECSP930933A (es) Composicion farmaceutica y procedimiento para prepararla
EP1132093A4 (en) MEANS FOR PREVENTING OR PREVENTING MYOCARDITIS, CARDIOMYOPATHY DILATUS AND HEART FAILURE CONTAINING NF-KAPPA B INHIBITORS AS AN ACTIVE INGREDIENT
AR034493A1 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
NO990440L (no) Preparat som innbefatter mupirocin og klorheksidin
KR910019620A (ko) 15-케토-프로스타글란딘 화합물을 사용한 췌장 질병의 치료
TR199802351T2 (xx) Topikal kullanım için bir veya birden fazla lokal anestezik ve anti-vajinit maddeler ihtiva eden anti-vajinit bileşimi.
WO1997030714A3 (en) Topical pharmaceutical composition containing heparin
YU39598A (sh) Upotreba duloksetina i njegova farmaceutska smeša
ES2192420T3 (es) Utilizacion de una composicion farmaceutica que comprende un agente anticanceroso y al menos un peptido.
ES2172682T3 (es) Preparaciones desodorantes con contenido en quitosano, clorohidrato de aluminio e inhibidores de esterasa.
ES2135254T3 (es) Procedimiento para la degradacion de quinolonas y naftiridonas.
ES2176702T3 (es) Antimicoticos con alta liberacion de sustancia activa.